Table 3.
P value | ||||||
---|---|---|---|---|---|---|
Control versus NDR | Control versus NPDR | Control versus PDR | NDR versus NPDR | NDR versus PDR | NPDR versus PDR | |
IL-1βa | 1.000 | 0.001∗∗ | <0.001∗∗ | 0.004∗∗ | <0.001∗∗ | 1.000 |
IL-2b | 0.975 | <0.001∗∗ | <0.001∗∗ | <0.001∗∗ | <0.001∗∗ | 0.034∗ |
IL-4b | 0.798 | <0.001∗∗ | <0.001∗∗ | <0.001∗∗ | <0.001∗∗ | 0.101 |
IL-5b | 0.794 | <0.001∗∗ | <0.001∗∗ | <0.001∗∗ | <0.001∗∗ | 0.048∗ |
IL-6a | 1.000 | 0.046∗ | <0.001∗∗ | 0.264 | 0.001∗∗ | 0.241 |
IL-10a | 1.000 | 0.487 | <0.001∗∗ | 1.000 | 0.001∗∗ | 0.051 |
IFN-γb | 0.668 | <0.001∗∗ | <0.001∗∗ | <0.001∗∗ | <0.001∗∗ | 0.072 |
TNF-αb | 0.186 | 0.041∗ | 0.006∗∗ | <0.001∗∗ | <0.001∗∗ | 0.362 |
VEGFb | 0.955 | 0.112 | <0.001∗∗ | 0.062 | <0.001∗∗ | 0.001∗∗ |
∗∗ P < 0.01; ∗P < 0.05; aKolmogorov-Smirnov test; banalysis of variance; NDR: nondiabetic retinopathy; NPDR: nonproliferative diabetic retinopathy; PDR: proliferative diabetic retinopathy.